SERUM CYTOKINES (IL-6, TNF-ALPHA, IL-1-BETA AND IFN-GAMMA) IN ANKYLOSING-SPONDYLITIS - A CLOSE CORRELATION BETWEEN SERUM IL-6 AND DISEASE-ACTIVITY AND SEVERITY

被引:1
作者
GRATACOS, J [1 ]
COLLADO, A [1 ]
FILELLA, X [1 ]
SANMARTI, R [1 ]
CANETE, J [1 ]
LLENA, J [1 ]
MOLINA, R [1 ]
BALLESTA, A [1 ]
MUNOZGOMEZ, J [1 ]
机构
[1] UNIV BARCELONA,HOSP CLIN & PROV,DEPT BIOCHEM,BARCELONA 7,SPAIN
来源
BRITISH JOURNAL OF RHEUMATOLOGY | 1994年 / 33卷 / 10期
关键词
INTERLEUKIN; SPONDYLOARTHROPATHY; SERA;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of our study was to analyse the serum interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta) and interferon-gamma(IFN-gamma) levels in patients with AS and their relationship with disease activity. An ELISA test was used to analyse serum cytokine (IL-6, TNF-alpha, IL-1beta and IFN-gamma) levels in 69 patients with AS. Results were compared with those from 43 patients with RA and 36 patients with non-inflammatory back pain. The relationship between serum concentrations of the different cytokines and parameters of disease activity and severity in AS patients was also evaluated. IL-6 and TNF-alpha serum levels, but not IL-1beta and IFN-gamma, were significantly higher in AS than in NIBP. However, patients with RA showed higher serum levels of IL-6, TNF-alpha and IFN-gamma than both AS and NIBP patients. In AS, IL-6 correlated with clinical parameters of disease activity with significant correlation being observed with laboratory parameters of inflammation such as ESR, CRP, platelet count and clinical parameters of severity such as vertebral mobility. TNF-alpha did not correlate with laboratory or clinical parameters of activity. Macrophagic cytokines (TNF-alpha and IL-6), are increased in AS patients and IL-6 closely correlated with the activity of the disease.
引用
收藏
页码:927 / 931
页数:5
相关论文
共 27 条
[1]  
AREND WP, 1993, TXB RHEUMATOLOGY, P227
[2]  
BALDWILL RR, 1989, IMMUNOL TODAY, V10, P299
[3]   C-REACTIVE PROTEIN-LEVELS AS A DIRECT INDICATOR OF INTERLEUKIN-6 LEVELS IN HUMANS INVIVO [J].
BATAILLE, R ;
KLEIN, B .
ARTHRITIS AND RHEUMATISM, 1992, 35 (08) :982-983
[4]  
Bennett PH, 1968, POPULATION STUDIES R, P305
[5]  
BILGIC A, 1993, BR J RHEUMATOL S1, V32, P165
[6]  
BRENNAN F M, 1991, British Journal of Rheumatology, V30, P76
[7]  
CANNON JG, 1988, EUR J CLIN INVEST, V18, P53
[8]   INTERLEUKIN-6 IS THE MAJOR REGULATOR OF ACUTE PHASE PROTEIN-SYNTHESIS IN ADULT HUMAN HEPATOCYTES [J].
CASTELL, JV ;
GOMEZLECHON, MJ ;
DAVID, M ;
ANDUS, T ;
GEIGER, T ;
TRULLENQUE, R ;
FABRA, R ;
HEINRICH, PC .
FEBS LETTERS, 1989, 242 (02) :237-239
[9]   IMMUNOGLOBULIN-A AND IMMUNOGLOBULIN-C REACTIVE PROTEIN-LEVELS IN ANKYLOSING-SPONDYLITIS [J].
COLLADO, A ;
SANMARTI, R ;
BRANCOS, MA ;
KANTEREWICZ, E ;
GALLART, T ;
ROTESQUEROL, J ;
COBOS, A .
ANNALS OF THE RHEUMATIC DISEASES, 1987, 46 (09) :719-720
[10]   SERUM LEVELS OF SECRETORY IGA IN ANKYLOSING-SPONDYLITIS [J].
COLLADO, A ;
SANMARTI, R ;
SERRA, C ;
GALLART, T ;
CANETE, JD ;
GRATACOS, J ;
VIVES, J ;
MUNOZGOMEZ, J .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1991, 20 (03) :153-158